FDA NDC Directory · JSON-LD · Markdown

Pomalidomide

NDC 0480-4035 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209956
Dosage form / routeCAPSULE · ORAL
Active ingredientsPOMALIDOMIDE (4 mg/1)
Marketing started20260302
Package count1

External sources

Source: openFDA. Public-domain (CC0).